BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2167556)

  • 1. Interaction of Epstein-Barr viral (EBV) origin of replication (oriP) with EBNA-1 and cellular anti-EBNA-1 proteins.
    Wen LT; Lai PK; Bradley G; Tanaka A; Nonoyama M
    Virology; 1990 Sep; 178(1):293-6. PubMed ID: 2167556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Epstein-Barr virus nuclear antigen 1 with the viral latent origin of replication.
    Hearing J; Mülhaupt Y; Harper S
    J Virol; 1992 Feb; 66(2):694-705. PubMed ID: 1309908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the lymphocyte-derived Epstein-Barr virus nuclear antigen EBNA-1 with its DNA-binding sites.
    Jones CH; Hayward SD; Rawlins DR
    J Virol; 1989 Jan; 63(1):101-10. PubMed ID: 2535719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of EBNA-1 in arresting replication forks at the Epstein-Barr virus oriP family of tandem repeats.
    Dhar V; Schildkraut CL
    Mol Cell Biol; 1991 Dec; 11(12):6268-78. PubMed ID: 1658629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of anti-EBNA-1 protein by 12-O-tetradecanoylphorbol-13-acetate treatment of human lymphoblastoid cells.
    Wen LT; Tanaka A; Nonoyama M
    J Virol; 1989 Aug; 63(8):3315-22. PubMed ID: 2545906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication.
    Harrison S; Fisenne K; Hearing J
    J Virol; 1994 Mar; 68(3):1913-25. PubMed ID: 8107251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus nuclear antigen-1-dependent and -independent oriP-binding cellular proteins.
    Kusano S; Tamada K; Senpuku H; Harada S; Ito S; Yanagi K
    Intervirology; 2001; 44(5):283-90. PubMed ID: 11684889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure.
    Inoue N; Harada S; Honma T; Kitamura T; Yanagi K
    Virology; 1991 May; 182(1):84-93. PubMed ID: 1850915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cellular factors that bind specifically to the Epstein-Barr virus origin of DNA replication.
    Oh SJ; Chittenden T; Levine AJ
    J Virol; 1991 Jan; 65(1):514-9. PubMed ID: 1845905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The minimal replicator of Epstein-Barr virus oriP.
    Yates JL; Camiolo SM; Bashaw JM
    J Virol; 2000 May; 74(10):4512-22. PubMed ID: 10775587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive binding of EBNA1 protein to the Epstein-Barr virus replication origin, oriP, with distortion of DNA structure during latent infection.
    Hsieh DJ; Camiolo SM; Yates JL
    EMBO J; 1993 Dec; 12(13):4933-44. PubMed ID: 8262037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein and sequence requirements for the recruitment of the human origin recognition complex to the latent cycle origin of DNA replication of Epstein-Barr virus oriP.
    Julien MD; Polonskaya Z; Hearing J
    Virology; 2004 Sep; 326(2):317-28. PubMed ID: 15302216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-stranded structures are present within plasmids containing the Epstein-Barr virus latent origin of replication.
    Orlowski R; Miller G
    J Virol; 1991 Feb; 65(2):677-86. PubMed ID: 1846191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr nuclear antigen 1 mediates a DNA loop within the latent replication origin of Epstein-Barr virus.
    Frappier L; O'Donnell M
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10875-9. PubMed ID: 1660154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
    Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
    Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
    Reisman D; Sugden B
    Mol Cell Biol; 1986 Nov; 6(11):3838-46. PubMed ID: 3025615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between Epstein-Barr virus-determined nuclear antigen (EBNA) and the viral DNA.
    Gergely L; Luka J; Klein G
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():2043-8. PubMed ID: 6094716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor.
    Sung NS; Wilson J; Davenport M; Sista ND; Pagano JS
    Mol Cell Biol; 1994 Nov; 14(11):7144-52. PubMed ID: 7935429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation of DNA replication within oriP is dispensable for stable replication of the latent Epstein-Barr virus chromosome after infection of established cell lines.
    Norio P; Schildkraut CL; Yates JL
    J Virol; 2000 Sep; 74(18):8563-74. PubMed ID: 10954558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.